Scientists test nasal spray to fight Alzheimer's brain toxins
NCT ID NCT07187141
Summary
This early-stage study tested the safety of a new nasal spray called Protollin in people with early Alzheimer's symptoms. The spray aims to stimulate the body's immune system to help clear toxic amyloid protein from the brain, which is thought to drive the disease. Researchers gave the spray to 16 participants to find the highest safe dose and see if it triggered the intended immune response.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALZHEIMER DISEASE (AD) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Brigham and Women's Hospital
Boston, Massachusetts, 02115, United States
Conditions
Explore the condition pages connected to this study.